Primary conjunctival follicular lymphoma treated with the anti-CD20 antibody rituximab and low-dose involved-field radiotherapy

Jpn J Ophthalmol. 2007 Mar-Apr;51(2):149-51. doi: 10.1007/s10384-006-0407-0. Epub 2007 Apr 6.

Authors

Masayuki Takahira, Hirokazu Okumura, Hiroshi Minato, Norimasa Urushisaki, Mayumi Sakurai, Kazuhisa Sugiyama

PMID: 17401629
DOI: 10.1007/s10384-006-0407-0

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antibodies, Monoclonal / therapeutic use*
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20 / immunology
Combined Modality Therapy
Conjunctival Neoplasms / drug therapy
Conjunctival Neoplasms / pathology
Conjunctival Neoplasms / radiotherapy
Conjunctival Neoplasms / therapy*
Humans
Lymphoma, Follicular / drug therapy
Lymphoma, Follicular / pathology
Lymphoma, Follicular / radiotherapy
Lymphoma, Follicular / therapy*
Male
Radiotherapy Dosage
Radiotherapy, Adjuvant*
Rituximab

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Murine-Derived
Antigens, CD20
Rituximab